ATE321041T1 - Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten - Google Patents

Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten

Info

Publication number
ATE321041T1
ATE321041T1 AT02722126T AT02722126T ATE321041T1 AT E321041 T1 ATE321041 T1 AT E321041T1 AT 02722126 T AT02722126 T AT 02722126T AT 02722126 T AT02722126 T AT 02722126T AT E321041 T1 ATE321041 T1 AT E321041T1
Authority
AT
Austria
Prior art keywords
alkoxycarbonylamino
antagonists
carboxylic acid
acid derivatives
heteroaryl carboxylic
Prior art date
Application number
AT02722126T
Other languages
English (en)
Inventor
Francisco Javier Lopez-Tapia
Dov Nitzan
Counde O'yang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE321041T1 publication Critical patent/ATE321041T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT02722126T 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten ATE321041T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27284901P 2001-03-02 2001-03-02

Publications (1)

Publication Number Publication Date
ATE321041T1 true ATE321041T1 (de) 2006-04-15

Family

ID=23041569

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02722126T ATE321041T1 (de) 2001-03-02 2002-02-25 Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten

Country Status (14)

Country Link
US (1) US6569860B2 (de)
EP (1) EP1368345B1 (de)
JP (1) JP2004526721A (de)
KR (1) KR100589990B1 (de)
CN (1) CN1280289C (de)
AR (1) AR033429A1 (de)
AT (1) ATE321041T1 (de)
BR (1) BR0207730A (de)
CA (1) CA2438813C (de)
DE (1) DE60210058T2 (de)
ES (1) ES2260425T3 (de)
MX (1) MXPA03007864A (de)
WO (1) WO2002070514A1 (de)
ZA (1) ZA200306283B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
EP1596858A1 (de) * 2003-02-14 2005-11-23 Medical Research Council Ip-rezeptor antagonisten zur behandlung von erkrankungen des uterus
EP1937695B1 (de) * 2005-10-20 2012-08-29 LG Chem, Ltd. Neue organische silanverbindung
KR100840114B1 (ko) * 2005-10-20 2008-06-19 주식회사 엘지화학 점착제 조성물
AR069650A1 (es) * 2007-12-14 2010-02-10 Actelion Pharmaceuticals Ltd Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
WO2014143592A1 (en) 2013-03-12 2014-09-18 Allergan, Inc. Inhibition of neovascularization by inhibition of prostanoid ip receptors
US9295665B2 (en) 2013-03-12 2016-03-29 Allergan, Inc. Inhibition of neovascularization by simultaneous inhibition of prostanoid IP and EP4 receptors
TWI903299B (zh) 2018-03-08 2025-11-01 美商英塞特公司 作為PI3K-γ抑制劑之胺基吡嗪二醇化合物
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
EP4119138A1 (de) * 2021-07-12 2023-01-18 Universität Hamburg Dhodh-inhibitoren und ihre verwendung als antivirale mittel

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908842A (en) 1995-12-08 1999-06-01 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
US6184242B1 (en) 1997-09-04 2001-02-06 Syntex Usa (Llc) 2-(substituted-phenyl)amino-imidazoline derivatives
AU1176299A (en) * 1997-11-26 1999-06-15 Yoshitomi Pharmaceutical Industries, Ltd. Tryptase inhibitors comprising heterocyclic amide compounds
CN1173950C (zh) * 1998-10-06 2004-11-03 大日本制药株式会社 2,3-二取代的吡啶衍生物、其制备方法、含有其的药物组合物和用于制备中的中间体
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
GEP20053476B (en) * 1999-08-12 2005-03-25 Upjohn Co 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents
NZ521028A (en) 2000-03-16 2004-07-30 F Carboxylic acid derivatives as IP antagonists

Also Published As

Publication number Publication date
MXPA03007864A (es) 2003-12-04
CA2438813C (en) 2008-07-29
ES2260425T3 (es) 2006-11-01
DE60210058D1 (de) 2006-05-11
CA2438813A1 (en) 2002-09-12
EP1368345B1 (de) 2006-03-22
US6569860B2 (en) 2003-05-27
DE60210058T2 (de) 2006-11-09
US20020169171A1 (en) 2002-11-14
BR0207730A (pt) 2004-03-23
CN1280289C (zh) 2006-10-18
KR20030078962A (ko) 2003-10-08
JP2004526721A (ja) 2004-09-02
AR033429A1 (es) 2003-12-17
WO2002070514A1 (en) 2002-09-12
KR100589990B1 (ko) 2006-06-15
ZA200306283B (en) 2004-11-15
EP1368345A1 (de) 2003-12-10
CN1494544A (zh) 2004-05-05

Similar Documents

Publication Publication Date Title
NO20024387D0 (no) Karboksylsyrederivater som IP-antagonister
ATE392897T1 (de) Chinolinderivate als npy antagonisten
NO20041235L (no) Kinolinderivater som neuropeptid Y antagonister
ATE441631T1 (de) Phenylpiperidinderivate als serotonin- wiederaufnahmehemmer
ATE461191T1 (de) N-substituierte 2-oxodihydropyridinderivate als npy antagonisten
DE60110844D1 (de) Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
ATE354570T1 (de) 5,6-diaryl-pyrazineamidderivate als cb1 antagonisten
NO20054957D0 (no) Subtituerte karboksylsyrer
DE50212761D1 (de) Neuartige aminodicarbonsäurederivate
NO20032142D0 (no) Substituerte 2-fenylaminoimidazolin-fenylketon-derivater som IP-antagonister
EE200200490A (et) Kinoliini derivaadid alfa-2 antagonistidena
EE200300447A (et) Asendatud bensofuraan-2-karboksamiidide derivaadid
DE60218213D1 (de) Pyridyloxyalkancarbonsäureamid-derivate verwendbar als fungizide
ATE309994T1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
ATE321041T1 (de) Alkoxycarbonylamino-heteroaryl- carbonsäurederivate als ip-antagonisten
DE60017110D1 (de) Biphenylderivate als neurokinin-1 antagonisten
ATE418542T1 (de) Als ccr5-antagonisten verwendbare aryloxim- piperazine
DE60226419D1 (de) Somatostatin-antagonisten
ATE305001T1 (de) Propansäure-derivate als integrin-rezeptor- antagonisten
DE50206910D1 (de) Substituierte y-lactonverbindungen als nmda-antagonisten
ATE280161T1 (de) Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
ATE367379T1 (de) Quinolin-derivate als antientzündungsmittel
ATE382601T1 (de) Substituierte 4-aminocyclohexanolderivate
NO20042664L (no) Karboksylsyrederivat
ATE468321T1 (de) Neue alpha-oxidierte carbonsäure-phenethylamid- derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368345

Country of ref document: EP

REN Ceased due to non-payment of the annual fee